Skip to main content

. 1957 Nov 23;2(5055):1219–1221. doi: 10.1136/bmj.2.5055.1219

Excretion of Mecamylamine after Intravenous and Oral Administration

K D Allanby, J R Trounce

PMCID: PMC1962772 PMID: 13472094

1219

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BAER J. E., BEYER K. H., PAULSON S. F., RUSSO H. F. Renal elimination of 3-methylaminoisocamphane hydrochloride (mecamylamine). Am J Physiol. 1956 Jul;186(1):180–186. doi: 10.1152/ajplegacy.1956.186.1.180. [DOI] [PubMed] [Google Scholar]
DOYLE A. E., MURPHY E. A., NEILSON G. H. The hypotensive action of mercamylamine. Br Med J. 1956 Nov 24;2(5003):1209–1211. doi: 10.1136/bmj.2.5003.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
DOYLE A. E., SMIRK F. H. Drug therapy in hypertension; a critical review. Practitioner. 1955 Feb;174(1040):135–143. [PubMed] [Google Scholar]
FORD R. V., MADISON J. C., MOYER J. H. Pharmacology of mecamylamine. Am J Med Sci. 1956 Aug;232(2):129–143. doi: 10.1097/00000441-195608000-00002. [DOI] [PubMed] [Google Scholar]
HARINGTON M. The absorption and excretion of hexamethonium salts. Clin Sci. 1953 May;12(2):185–198. [PubMed] [Google Scholar]
MCQUEEN E. G., SMIRK F. H. Drug treatment of hypertension. Postgrad Med J. 1956 Feb;32(364):85–91. doi: 10.1136/pgmj.32.364.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
MCQUEEN E. G., SMIRK F. H. Use of mecamylamine in the management of hypertension. Br Med J. 1957 Feb 23;1(5016):422–425. doi: 10.1136/bmj.1.5016.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
McMICHAEL J., MURPHY E. A. Methonium treatment of severe and malignant hypertension. J Chronic Dis. 1955 May;1(5):527–535. doi: 10.1016/0021-9681(55)90064-3. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES